MGMT and central nervous system cancer: Because both are alkylating agents, the repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) is certainly a first barrier that is associated with increased tumor resistance.2, 3 The p53 status has also been proposed to act in an opposite manner in glioma cell resistance to TMZ or CNUs.